ABOUT US

A Sarun Pharma (short for pharmaceutical company) is a business that focuses on the research, development, production, and distribution of drugs and medical products to improve health outcomes. These companies play a vital role in healthcare systems worldwide by developing medications to treat, prevent, and cure diseases.

Key Activities of Pharma Companies:

  1. Research and Development (R&D):

    • Invest heavily in discovering new drugs, therapies, and medical solutions.
    • Conduct clinical trials to ensure the safety and efficacy of new medications.
    • Develop formulations for various dosage forms, including tablets, capsules, injections, and topical solutions.
  2. Manufacturing:

    • Produce pharmaceutical products on a large scale, adhering to strict quality control standards (e.g., Good Manufacturing Practices or GMP).
    • Manufacture both branded drugs (proprietary) and generic drugs (off-patent).
  3. Regulatory Compliance:

    • Obtain necessary approvals from regulatory bodies like the FDA (U.S.), EMA (Europe), or WHO (globally).
    • Ensure compliance with national and international regulations regarding drug safety, efficacy, and labeling.
  4. Marketing and Distribution:

    • Promote medications to healthcare professionals through marketing strategies.
    • Supply products to hospitals, clinics, pharmacies, and retailers.
  5. Therapeutic Areas:

    • Focus on various medical areas, such as oncology, cardiology, neurology, infectious diseases, and more.

Types of Pharma Companies:

  1. Innovator Companies: Focus on developing new drugs and are usually involved in extensive R&D (e.g., Pfizer, Novartis).
  2. Generic Manufacturers: Produce off-patent medications at a lower cost (e.g., Teva Pharmaceuticals).
  3. Biotech Firms: Specialize in biologics, vaccines, and gene therapies (e.g., Amgen, Moderna).
  4. Contract Research and Manufacturing Organizations (CROs/CMOs): Provide services for drug development and manufacturing to other companies.

Challenges in the Pharma Industry:

  • High costs and risks associated with drug development.
  • Regulatory hurdles and compliance requirements.
  • Competition from generic drugs.
  • Addressing unmet medical needs and global health challenges.